Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

849 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Transplant-related mortality and long-term graft function are significantly influenced by cell dose in patients undergoing allogeneic marrow transplantation.
Dominietto A, Lamparelli T, Raiola AM, Van Lint MT, Gualandi F, Berisso G, Bregante S, Di Grazia C, Soracco M, Pitto A, Frassoni F, Bacigalupo A. Dominietto A, et al. Among authors: bacigalupo a. Blood. 2002 Dec 1;100(12):3930-4. doi: 10.1182/blood-2002-01-0339. Epub 2002 Aug 1. Blood. 2002. PMID: 12393584 Free article.
Total body irradiation correlates with chronic graft versus host disease and affects prognosis of patients with acute lymphoblastic leukemia receiving an HLA identical allogeneic bone marrow transplant.
Corvò R, Paoli G, Barra S, Bacigalupo A, Van Lint MT, Franzone P, Frassoni F, Scarpati D, Bacigalupo A, Vitale V. Corvò R, et al. Among authors: bacigalupo a. Int J Radiat Oncol Biol Phys. 1999 Feb 1;43(3):497-503. doi: 10.1016/s0360-3016(98)00441-6. Int J Radiat Oncol Biol Phys. 1999. PMID: 10078628
Retrospective comparison of bone marrow and granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells for allogeneic stem cell transplantation using HLA identical sibling donors in myelodysplastic syndromes.
Guardiola P, Runde V, Bacigalupo A, Ruutu T, Locatelli F, Boogaerts MA, Pagliuca A, Cornelissen JJ, Schouten HC, Carreras E, Finke J, van Biezen A, Brand R, Niederwieser D, Gluckman E, de Witte TM; Subcommittee for Myelodysplastic Syndromes of the Chronic Leukaemia Working Group of the European Blood and Marrow Transplantation Group. Guardiola P, et al. Among authors: bacigalupo a. Blood. 2002 Jun 15;99(12):4370-8. doi: 10.1182/blood.v99.12.4370. Blood. 2002. PMID: 12036864 Free article.
Donor lymphocyte infusion for relapsed chronic myelogenous leukemia: prognostic relevance of the initial cell dose.
Guglielmi C, Arcese W, Dazzi F, Brand R, Bunjes D, Verdonck LF, Schattenberg A, Kolb HJ, Ljungman P, Devergie A, Bacigalupo A, Gomez M, Michallet M, Elmaagacli A, Gratwohl A, Apperley J, Niederwieser D. Guglielmi C, et al. Among authors: bacigalupo a. Blood. 2002 Jul 15;100(2):397-405. doi: 10.1182/blood.v100.2.397. Blood. 2002. PMID: 12091328 Free article.
Transplantation of mobilized peripheral blood cells to HLA-identical siblings with standard-risk leukemia.
Schmitz N, Beksac M, Hasenclever D, Bacigalupo A, Ruutu T, Nagler A, Gluckman E, Russell N, Apperley JF, Gorin NC, Szer J, Bradstock K, Buzyn A, Clark P, Borkett K, Gratwohl A; European Group for Blood and Marrow Transplantation. Schmitz N, et al. Among authors: bacigalupo a. Blood. 2002 Aug 1;100(3):761-7. doi: 10.1182/blood-2001-12-0304. Blood. 2002. PMID: 12130483 Free article. Clinical Trial.
Relevance of bone marrow cell dose on allogeneic transplantation outcomes for patients with acute myeloid leukemia in first complete remission: results of a European survey.
Rocha V, Labopin M, Gluckman E, Powles R, Arcese W, Bacigalupo A, Reiffers J, Iriondo A, Ringdén O, Ruutu T, Frassoni F; Acute Leukemia Working Party of the European Blood and Marrow Transplant Registry. Rocha V, et al. Among authors: bacigalupo a. J Clin Oncol. 2002 Nov 1;20(21):4324-30. doi: 10.1200/JCO.2002.11.058. J Clin Oncol. 2002. PMID: 12409331
849 results